Clover Health Corp (CLOV) - P/E multiplikatori

Clover Health Corp (CLOV) korporativ emblemasi va logotipi

Kompaniya hisobotlariga asoslangan P/E koeffitsiyentida yaqqol ko'ringan tebranishlar Clover Health Investments (CLOV) uchun xarajatlarni optimallashtirish maqsadida AI texnologiyalarini joriy etish bilan bog'liq. Barqarorlik esa uning Medicare Advantage innovatori sifatidagi maqomi va keksayganlar ishonchi orqali tiklanmoqda. Pragmatik biznes modeliga o'tish uning meme stock sifatidagi imidjini yo'q qilib, institutsional investorlarni jalb qildi. Grafikning narx harakati chegirmali kirish nuqtasini aniqlashga yordam beradi, bunda qiymat 215.20 darajasida barqarorlashmoqda.

cloverhealth.com (CLOV): P/E multiplikatori 04.07.2022dan 12.11.2026gacha

Clover Health Investments kompaniyasining tahliliy kesimlari

- aksiya kursi va ekspertlarning narx prognozi:
Narxlar dinamikasi grafigi cloverhealth.com|CLOV - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi ko'rsatkichlari:
Bozor kapitallashuvi Clover Health Investments, Corp.|CLOV - Kompaniyaning to‘liq qiymati
- kompaniyaning balans qiymati tafsilotlari:
Bitta aksiya hisobiga balans qiymati Clover Health|CLOV - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor qiymati cloverhealth.com|CLOV - Kompaniyaning umumiy aktivlari
- kompaniyaning majburiyatlari va likvidligi ma'lumotlari:
Umumiy qarzning xususiy kapitalga nisbati Clover Health Investments|CLOV - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Clover Health Inc|CLOV - Kompaniya qarzlari|Balans qiymatiga qarzlar Clover Health Investments, Corp.|CLOV - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli qarzi Clover Health|Shoshilinch likvidlik cloverhealth.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
CLOV - Kompaniyaning sof foydasi|Kutilayotgan sof daromad Clover Health Investments|CLOV - Narx-foyda koeffitsiyenti|Kelajakdagi narx-foyda multiplikatori Clover Health Investments, Corp.|CLOV - PEG multiplikatori|Biznes qiymatining amortizatsiya chegirilishidan oldingi operatsion foydaga nisbati Clover Health Investments, Corp.|CLOV - EBITDA operatsion foydasi|So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda Clover Health|CLOV - Bir aksiya uchun sof foyda (EPS TTM)|Choraklik EPS foyda o'sishi cloverhealth.com|CLOV - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yil uchun bir aksiya uchun sof foyda o'sishi prognozi Clover Health Investments
Kompaniyaning har tomonlama tahlili:CLOV (cloverhealth.com)
Clover Health Inc brend mahsuloti

P/E koeffitsiyenti sof foydaning bir birligining bozor qiymatini belgilaydi va aksiya narxining uning daromadlariga nisbatini hisobga olgan holda investitsiyalarning qoplanish muddatini o'lchaydi. Clover Health Investments (CLOV) uchun ushbu metrika Medicare Advantage sug'urta premiyalarini monetizatsiya qilish samaradorligini aks ettiradi; shuning uchun, taxminiy P/E koeffitsiyentining tendentsiyasi kompaniyaning tizimli sanoat risklariga nisbatan haqiqiy texnologik ustunligining ko'rsatkichi bo'lib xizmat qiladi.

Raqobatdosh kompaniyalar

UNH: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori CI|P/E multiplikatori Aflac Inc. (AFL)|Narxning foydaga nisbati Humana Health HUM|P/E multiplikatori Centene Health CNC|Molina Healthcare, Inc. - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati MMS (maximus.com)|OSCR: P/E multiplikatori|Narx-foyda koeffitsiyenti Claritev Corporation|Narxning foydaga nisbati Yuanbao Insurance|Narxning foydaga nisbati HIT|Narxning foydaga nisbati eHealth, Inc. (EHTH)|GOCO - Kapitalizatsiyaning foydaga nisbati|NeueHealth - Narx-foyda koeffitsiyenti|Reliance Global Group Inc - Narxning foydaga nisbati|LifeWallet - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati MultiPlan Inc.